首页 | 本学科首页   官方微博 | 高级检索  
     

IL-28B rs12979860位点与乙肝病毒感染后自发清除及干扰素治疗应答关系的Meta分析
引用本文:于风雪, 姜乐, 马宁, 张晓琳, 权媛, 刘殿武. IL-28B rs12979860位点与乙肝病毒感染后自发清除及干扰素治疗应答关系的Meta分析[J]. 中华疾病控制杂志, 2016, 20(7): 707-711. doi: 10.16462/j.cnki.zhjbkz.2016.07.016
作者姓名:于风雪  姜乐  马宁  张晓琳  权媛  刘殿武
作者单位:1. 河北医科大学第二医院科研处, 河北 石家庄 050000;;2. 河北医科大学流行病学教研室, 河北 石家庄 050017;;3. 河北省胸科医院结核科, 河北 石家庄 050041
基金项目:国家自然科学基金青年科学基金(81402729),河北省自然科学基金(H2015206152),河北省科技厅课题(13277732D)
摘    要:目的 探索白细胞介素28B(interleukin- 28B,IL-28B)基因rs12979860位点与乙型肝炎病毒(hepatitis B virus,HBV)感染后自发清除及干扰素治疗应答的关系。方法 检索2010年1月1日~2015年8月31日PubMed、Embase、中文科技期刊全文数据库、万方数据库、中国生物医学文献数据库、中国期刊全文数据库公开发表文献,对符合纳入和排除标准文献提取数据后采用Stata 12.0 软件进行Meta分析。结果 共纳入12篇文献,根据研究目的分为两组:A组为HBV自发清除组和持续感染组,共5篇文献;B组:干扰素治疗应答组和非应答组,共9篇文献。Meta分析结果:rs12979860位点与HBV感染后自发清除无关联(OR=0.96,95% CI:0.76~1.20,P=0.700);rs12979860位点与乙型肝炎e抗原阳性慢性HBV感染后干扰素治疗应答无关联(OR=0.93,95% CI:0.43~2.00,P=0.848),而突变基因型TC+TT 降低了乙型肝炎e抗原阴性慢性HBV感染后干扰素治疗应答(OR=0.47,95% CI:0.25~0.87,P=0.016)。结论 IL-28B基因的rs12979860位点突变基因型TC+TT降低了乙型肝炎e抗原阴性慢性HBV感染后干扰素治疗的应答。

关 键 词:基因   肝炎   乙型   慢性   Meta分析
收稿时间:2016-01-15
修稿时间:2016-04-20

Association of IL-28B rs12979860 with spontaneous HBV clearance and interferon treatment response: a Meta-analysis
YU Feng-xue, JIANG Le, MA Ning, ZHANG Xiao-lin, QUAN Yuan, LIU Dian-wu. Association of IL-28B rs12979860 with spontaneous HBV clearance and interferon treatment response: a Meta-analysis[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2016, 20(7): 707-711. doi: 10.16462/j.cnki.zhjbkz.2016.07.016
Authors:YU Feng-xue  JIANG Le  MA Ning  ZHANG Xiao-lin  QUAN Yuan  LIU Dian-wu
Affiliation:1. Department of Science and Technology, the Second Hospital of Hebei Medical University, Shijiazhuang 050000, China;;2. Department of Epidemiology, Hebei Medical University, Shijiazhuang 050017, China;;3. Department of Tuberculosis, the Chest Hospital of Hebei Province, Shijiazhuang 050041, China
Abstract:Objective To investigate the association of SNP-rs12979860 in Interleukin- 28B (IL-28B) gene with spontaneous Hepatitis B Virus (HBV)clearance and interferon treatment response in patients with chronic hepatitis B. Methods Data published from January 1, 2010 to August 31, 2015 were retrieved from PubMed,Embase,CNKI,Wan-fang database,VIP database and CBM disc. The meta-analysis was performed to analyze the data. Results Twelve papers were obtained and were divided into two groups according to the purpose of the study. Group A included five articles about rs12979860 and spontaneous HBV clearance, and group B included nine articles about rs12979860 and interferon treatment response. The meta-analysis showed that there was no association between rs12979860 and spontaneous HBV clearance (OR=0.96,95% CI:0.76-1.20,P=0.700) and the response after interferon treatment for HBeAg-positive patients (OR=0.93, 95% CI:0.43-2.00,P=0.848), respectively. There was positive correlation between rs12979860 and the response after interferon treatment for HBe-negative patients, which manifested that the mutant genotype TC+TT significantly reduced the response after interferon treatment for HB e-negative patients. (total OR=0.47, 95% CI:0.25-0.87,P=0.016). Conclusions The mutant genotype TC+TT located on rs12979860 from gene IL-28B reduced the response after the interferon treatment for HBe-negative patients.
Keywords:Genes  Hepatitis B, chronic  Meta-analysis
本文献已被 万方数据 等数据库收录!
点击此处可从《中华疾病控制杂志》浏览原始摘要信息
点击此处可从《中华疾病控制杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号